Entourage Health Announces Preliminary Record Q2 Revenues of $13.6 Million and Confirms Financial Results Call to be Held on August 10, 2021 at 10 a.m. ET
July 20, 2021 08:05 ET
|
Entourage Health Corp.
TORONTO, July 20, 2021 (GLOBE NEWSWIRE) -- Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:WDDMF) (FSE:4WE) (“Entourage” or the “Company”), is pleased to announce preliminary...
Entourage Health Announces Debut of New Ticker “ENTG” on TSX Venture
July 16, 2021 08:00 ET
|
Entourage Health Corp.
TORONTO, July 16, 2021 (GLOBE NEWSWIRE) -- Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:WDDMF) (FSE:4WE) (“Entourage” or the “Company”), is pleased to announce that as part of...
WeedMD Inc. and CannTx Life Sciences Sign Definitive Acquisition Agreement and Confirm Corporate Name as Entourage Health Corp.
July 14, 2021 07:15 ET
|
WeedMD Rx Inc.
On closing, merged company to combine innovative medical business, low-cost cultivation, specialized craft cannabis, micropropagation, and solventless extraction capabilitiesTop-selling, award-winning...
WeedMD Inc. Announces Intent to Change Corporate Name to Entourage Health Corp.
July 05, 2021 08:15 ET
|
WeedMD Rx Inc.
Company reports results of Annual General & Special Meeting of Shareholders held on June 30, 2021 which includes overwhelming shareholder approval for corporate rebrandCompany confirms the...
WeedMD Reports First Quarter 2021 Financial Results with 102% Record Increase in Sequential Net Revenue Growth
June 29, 2021 07:15 ET
|
WeedMD Rx Inc.
Total revenue (before excise duties) of $12.9 million in Q1 2021, represents over 7% favourability over the $12.0 million Q1 2021 guidance previously providedNet revenue of $10.3 million in Q1 2021,...
WeedMD and Privately Owned CannTx Life Sciences Sign Letter of Intent to Create a Cannabis Cultivation and Consumer-Centric Product Portfolio
May 31, 2021 08:05 ET
|
WeedMD Rx Inc.
Strategic acquisition of innovative, specialized cannabis operator will fold in micro-propagation technology, a craft portfolio, and solventless extraction capabilities Complementary operations and...
WeedMD Reports Fiscal Year 2020 Financial Results and First Quarter 2021 Preliminary Gross Revenue of $12 Million
May 31, 2021 07:24 ET
|
WeedMD Rx Inc.
Net revenue increased 41% YOY to $29.4 million for the full year ended December 31, 2020Kilograms harvested in 2020 grew 88% over prior year to 33,751 with more Grade A flowerWeighted average cost per...
WeedMD to Host Fiscal Year End 2020 Conference Call on May 31st
May 21, 2021 08:18 ET
|
WeedMD Rx Inc.
Company financials to be filed after market on May 28, 2021 and operational outlook to be provided during call, including first quarter 2021 record milestones achieved TORONTO, May 21, 2021 (GLOBE...
WeedMD to Host Fiscal Year-End 2020 Conference Call on April 30, 2021
April 09, 2021 09:02 ET
|
WeedMD Rx Inc.
TORONTO, April 09, 2021 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally licensed producer and distributor of medical-grade cannabis,...
WeedMD Announces Supplemental Listing of Warrants
March 29, 2021 07:21 ET
|
WeedMD Rx Inc.
TORONTO, March 29, 2021 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally licensed producer and distributor of medical-grade cannabis, is...